Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma

NCT07674342 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Proximal Gastric or Gastroesophageal Junction Adenocarcinoma

Interventions

RADIATION: Short-course Radiotherapy
DRUG: Neoadjuvant Serplulimab and SOX Chemotherapy

Sponsor

Tongji Hospital